Publication:
Understanding the use of evidence in the WHO Classification of Tumours: a protocol for an evidence gap map of the classification of tumours of the lung

dc.contributor.authorDel Aguila Mejía, Javier
dc.contributor.authorArmon, Subasri
dc.contributor.authorCampbell, Fiona
dc.contributor.authorColling, Richard
dc.contributor.authorChechlińska, Magdalena
dc.contributor.authorKowalewska, Magdalena
dc.contributor.authorPollan-Santamaria, Marina
dc.contributor.authorHoldenrieder, Stefan
dc.contributor.authorTan, Puay Hoon
dc.contributor.authorCree, Ian A
dc.contributor.authorIndave Ruiz, Blanca Iciar
dc.date.accessioned2023-04-17T09:19:52Z
dc.date.available2023-04-17T09:19:52Z
dc.date.issued2022-10-11
dc.description.abstractIntroduction: There are gaps in the evidence base of tumour classification despite being essential for cancer diagnosis, treatment and patient care. The WHO in charge of the production of an updated international classification, the WHO Classification of Tumours (WCT), aims to adapt evidence gap map (EGM) methodology to inform future editions of the WCT, by providing a visual summary of the existing evidence. Methods and analysis: Bibliographical references used in the WCT fifth edition of Tumours of the Lung (Thoracic Tumours volume) will be used as search results of a literature search. A descriptive analysis of the cited evidence for tumour types and descriptors will be drafted and plotted in EPPI-Reviewer to develop a visual evidence map. The resulting EGM will reflect the number of cited studies in the size of the spheres, and the level of evidence by applying a four-colour code (red=low level evidence, orange=moderate level, green=high level and blue=unclassifiable). Overview of the findings will be provided in narrative form and a report will discuss the overall stage of cited research in the WCT and will include analysis of gaps, under-researched categories of tumour descriptors and pockets of low-level evidence. Ethics and dissemination: No ethics approval will be required as this is a study of previously published material. Findings of the EGM will be published and used to guide editors, stakeholders and researchers for future research planning and related decision-making, especially for the development of future editions of the WCT.es_ES
dc.description.peerreviewedes_ES
dc.format.number10es_ES
dc.format.pagee061240es_ES
dc.format.volume12es_ES
dc.identifier.citationBMJ Open. 2022 Oct 11;12(10):e061240.es_ES
dc.identifier.doi10.1136/bmjopen-2022-061240es_ES
dc.identifier.e-issn2044-6055es_ES
dc.identifier.journalBMJ openes_ES
dc.identifier.pubmedID36220326es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15820
dc.language.isoenges_ES
dc.publisherBMJ Publishing Groupes_ES
dc.relation.publisherversionhttps://doi.org/10.1136/bmjopen-2022-061240es_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución-NoComercial 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.subjectOncologyes_ES
dc.subjectPathologyes_ES
dc.subjectRespiratory tract tumourses_ES
dc.subject.meshLung Neoplasmses_ES
dc.subject.meshThoracic Neoplasmses_ES
dc.subject.meshHumanses_ES
dc.subject.meshWorld Health Organizationes_ES
dc.titleUnderstanding the use of evidence in the WHO Classification of Tumours: a protocol for an evidence gap map of the classification of tumours of the lunges_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationcb3b77d8-c78c-4238-9b9d-c1171ff3ab51
relation.isAuthorOfPublication.latestForDiscoverycb3b77d8-c78c-4238-9b9d-c1171ff3ab51

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
UnderstandingUseEvidenceWHO_2022.pdf
Size:
840.12 KB
Format:
Adobe Portable Document Format
Description: